Benchmarking Maintenance Therapy Survival in First-Line Platinum-Based Chemotherapy–Treated Patients with Advanced Urothelial Carcinoma Using Simulated Disease Modeling

OBJECTIVE: First-line (1L) maintenance avelumab prolonged overall survival (OS) in patients with advanced urothelial carcinoma (aUC) in JAVELIN Bladder 100. OS was measured from maintenance initiation in patients with disease control following 1L platinum-based therapy (PBT). The OS impact of mainte...

Descripción completa

Detalles Bibliográficos
Autores principales: Galsky, Matthew D, Wirtz, Heidi S, Bloudek, Brian, Hepp, Zsolt, Farrar, Mallory, Timmons, Jack, Lenero, Enrique, Powles, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290854/
https://www.ncbi.nlm.nih.gov/pubmed/37366420
http://dx.doi.org/10.2147/CLEP.S409791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290854/
https://www.ncbi.nlm.nih.gov/pubmed/37366420
http://dx.doi.org/10.2147/CLEP.S409791

Ejemplares similares